231 results on '"Bok, Karin"'
Search Results
2. 12 Vaccine Candidates for Novel Pathogens
3. 12.1 In Focus: Novel Manufacturing Platforms for Pandemic Preparedness and Emergency Response
4. Mucosal vaccines for SARS-CoV-2: scientific gaps and opportunities—workshop report
5. Publisher Correction: A non-human primate model for human norovirus infection
6. Multi-site observational maternal and infant COVID-19 vaccine study (MOMI-vax): a study protocol
7. Accelerated COVID-19 vaccine development: milestones, lessons, and prospects
8. Prototype Pathogens for Vaccine and Monoclonal Antibody Countermeasure Development: NIAID Workshop Process and Outcomes for Viral Families of Pandemic Potential
9. Unique safety issues associated with virus-vectored vaccines: Potential for and theoretical consequences of recombination with wild type virus strains
10. Kaiser Permanente Northern California pregnancy database: Description and proof of concept study
11. Vaccine purchasing groups in the United States: An overview of their policies and practices
12. Mapping and modeling of a strain-specific epitope in the Norwalk virus capsid inner shell
13. Safety, immunogenicity, and effectiveness of COVID-19 vaccines for pregnant persons: A protocol for systematic review and meta analysis
14. Safety of COVID-19 vaccines during pregnancy: A systematic review and meta-analysis
15. Safety, reactogenicity, immunogenicity, and effectiveness of COVID-19 vaccines for pregnant persons: A protocol for a living systematic review and meta-analysis
16. Sequential Gastroenteritis Outbreaks in a Single Year Caused by Norovirus Genotypes GII.2 and GII.6 in an Institutional Setting
17. An introduction to the Marburg virus vaccine consortium, MARVAC
18. Prototype Pathogen Approach for Vaccine and Monoclonal Antibody Development: A Critical Component of the NIAID Plan for Pandemic Preparedness.
19. Immunogenicity and specificity of norovirus Consensus GII.4 virus-like particles in monovalent and bivalent vaccine formulations
20. Prototype Pathogen Approach for Vaccine and Monoclonal Antibody Development: A Critical Component of the NIAID Plan for Pandemic Preparedness
21. Chimpanzees as an animal model for human norovirus infection and vaccine development
22. Rotavirus Genotypes among Hospitalized Children in Egypt, 2000–2002
23. Additional file 3 of Multi-site observational maternal and infant COVID-19 vaccine study (MOMI-vax): a study protocol
24. Additional file 2 of Multi-site observational maternal and infant COVID-19 vaccine study (MOMI-vax): a study protocol
25. Seroprevalence of Norovirus genogroup IV antibodies among humans, Italy, 2010-2011
26. Genetic characterization of feline calicivirus strains associated with varying disease manifestations during an outbreak season in Missouri (1995–1996)
27. Visualization of feline calicivirus replication in real-time with recombinant viruses engineered to express fluorescent reporter proteins
28. Safety of COVID-19 Vaccines During Pregnancy: A Systematic Review and Meta-Analysis
29. A capsid gene-based real-time reverse transcription polymerase chain reaction assay for the detection of marine vesiviruses in the Caliciviridae
30. Safety of components and platforms of COVID-19 vaccines considered for use in pregnancy: A rapid review
31. Inhibition of norovirus replication by morpholino oligomers targeting the 5′-end of the genome
32. Safety of COVID-19 vaccines, their components or their platforms for pregnant women: A rapid review
33. Norovirus Gastroenteritis in Immunocompromised Patients
34. Genetic associations with a fever after measles-containing vaccines
35. Prevalence and genetic characterization of caliciviruses among children hospitalized for acute gastroenteritis in the United States
36. Molecular Characterization and Genetic Variation of the VP7 Gene of Human Rotaviruses Isolated in Paraguay
37. Rotavirus antigenaemia and viraemia: a common event?
38. Parental risk factors for fever in their children 7–10 days after the first dose of measles-containing vaccines
39. 2649. Measles-Containing Vaccination Resulted in a Balanced Cytokine Profile Without Evidence of Immunosuppression in Healthy 12-Month-Old Children
40. Defining the interval for monitoring potential adverse events following immunization (AEFIs) after receipt of live viral vectored vaccines
41. Development of an Intervention to Reduce Pain and Prevent Syncope Related to Adolescent Vaccination
42. Malaria vaccine trials in pregnant women: An imperative without precedent
43. Identification of viral agents causing gastroenteritis among children in Buenos Aires, Argentina
44. Genetic associations with a fever after measles-containing vaccines.
45. Informing vaccine decision-making: A strategic multi-attribute ranking tool for vaccines—SMART Vaccines 2.0
46. Parental risk factors for fever in their children 7–10 days after the first dose of measles-containing vaccines.
47. 2275. Parental Risk Factors for Fever in their Children 7–10 Days After the First Dose of Measles-Containing Vaccines
48. Feasibility of a pilot intervention to reduce pain and syncope during adolescent vaccination
49. No association between influenza vaccination during pregnancy and adverse birth outcomes
50. Epidemiology of Norovirus Infection Among Immunocompromised Patients at a Tertiary Care Research Hospital, 2010–2013
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.